This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ratner, M. Pfizer stakes a claim in plant cell–made biopharmaceuticals. Nat Biotechnol 28, 107–108 (2010). https://doi.org/10.1038/nbt0210-107
Issue Date:
DOI: https://doi.org/10.1038/nbt0210-107
This article is cited by
-
Assessment of field-grown cellulase-expressing corn
Transgenic Research (2015)
-
Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Biotechnology Letters (2015)
-
Expression of an Avian Influenza Virus (H5N1) Hemagglutinin Gene in Transgenic Lotus corniculatus
Plant Molecular Biology Reporter (2012)
-
Adsorptive loss of secreted recombinant proteins in transgenic rice cell suspension cultures
Plant Cell Reports (2012)
-
Synthesis of distinctly different sets of antimicrobial activities by elicited plant cell suspension cultures
Plant Cell, Tissue and Organ Culture (PCTOC) (2011)